Related Experiment Video
Updated: Sep 28, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Hematologic effects of inactivating the Ras processing enzyme Rce1
Abigail L Aiyagari1, Brigit R Taylor, Vikas Aurora
1Department of Pediatrics, Gladstone Institute of Cardiovascular Disease, University of California, San Francisco (UCSF), CA 94143, USA.
Abstract:
Posttranslational processing of Ras proteins has attracted considerable interest as a potential target for anticancer drug discovery. Rce1 encodes an endoprotease that facilitates membrane targeting of Ras and other prenylated proteins by releasing the carboxyl-terminal 3 amino acids (ie, the -AAX of the CAAX motif). Homozygous Rce1 mutant embryos (Rce1(-/-)) die late in gestation. To characterize the role of Rce1 in hematopoiesis, we performed adoptive transfers and investigated cells from the recipients. Rce1(-/-) fetal liver cells rescued lethally irradiated recipients and manifested normal long-term repopulating potential in competitive repopulation assays. The recipients of Rce1(-/-) cells developed modest elevations in mature myeloid cells (neutrophils + monocytes), but remained well. Bone marrow cells from mice that received transplants of Rce1(-/-) activated extracellular signal-related kinase (ERK) normally in response to granulocyte-macrophage colony-stimulating factor. These data suggest that pharmacologic inhibitors of Rce1 will have minimal effects on normal hematopoietic cells.
Insights
Pharmacologic inhibitors targeting Rce1, an enzyme crucial for Ras protein processing, show minimal impact on normal hematopoietic cells. Rce1 mutant cells effectively repopulated recipients, indicating Rce1 is not essential for hematopoiesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ras proteins require posttranslational processing for membrane targeting.
- Rce1 is an endoprotease that cleaves the CAAX motif, releasing the C-terminal amino acids.
- Rce1 plays a role in Ras protein prenylation and localization.
Purpose of the Study:
- To investigate the role of Rce1 in hematopoiesis.
- To assess the impact of Rce1 deficiency on hematopoietic stem and progenitor cells.
- To evaluate the potential of Rce1 as a therapeutic target for anticancer drug discovery.
Main Methods:
- Adoptive transfer of Rce1(-/-) fetal liver cells into lethally irradiated recipients.
- Competitive repopulation assays to assess long-term repopulating potential.
- Analysis of hematopoietic cell populations and extracellular signal-related kinase (ERK) activation.
Main Results:
- Rce1(-/-) fetal liver cells rescued recipients and exhibited normal long-term repopulating capacity.
- Recipients of Rce1(-/-) cells showed modest increases in mature myeloid cells without adverse effects.
- Bone marrow cells from Rce1(-/-) transplants activated ERK normally in response to GM-CSF.
Conclusions:
- Rce1 is not essential for normal hematopoietic stem cell function and long-term repopulation.
- Pharmacologic inhibition of Rce1 is unlikely to significantly affect normal hematopoietic cells.
- These findings suggest Rce1 inhibitors may have a favorable safety profile for anticancer therapy.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
10:31The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics
Published on: October 6, 2016
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...